HIGHLIGHTS
- What: The authors evaluated the safety biodistribution and radiation dosimetry of the glucose analogue positron emission tomography (PET) agent labeled alpha-methyl-4-deoxy-4-[18F]fluoro-D-glucopyranoside ([18F]Me4FDG) with high sodium-glucose cotransporter and low glucose transporter (GLUT) affinity.
- Who: Barbara Katharina Geist et al. from the The study was approved by the Ethics Committee of the Medical University of Vienna (EK:, ) and by the Federal Office for Safety and Healthcare in Austria (EudraCT No:, ), trial registration number: NCT Subjects have published the article: EJNMMI Research In vivo assessment of safety biodistribution . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.